Market Exclusive

Analyst Upgrades – NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) Stock Gets Upgraded By Barclays from Underweight ➝ Equal Weight to

Analyst Ratings For NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)

Today, NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) stock received an upgrade by Barclays from Underweight ➝ Equal Weight with a price target of $5.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)
NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN) has insider ownership of 6.25% and institutional ownership of 80.80%.

Recent Trading Activity for NASDAQ:ACHN – Achillion Pharmaceuticals (NASDAQ:ACHN)
Shares of NASDAQ:ACHN – Achillion Pharmaceuticals closed the previous trading session at 3.65 down -0.05 1.35% with 3.630000114440918 shares trading hands.

Exit mobile version